
Glimu M 2mg/500mg Tablet SR
Marketer
Grapple Life Sciences Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg)
Overview Glimu M 2mg/500mg Tablet SR
Metformin/Glibenclamide 2mg/500mg Extended-Release Tablets are classified as antidiabetic agents, combining two medications to manage type 2 diabetes in adults. This dual-action formulation helps regulate blood glucose levels. Administer these tablets with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to hyperglycemia and potentially serious complications, including nephropathy, retinopathy, neuropathy, and peripheral vascular disease. This medication is a component of a comprehensive diabetes management plan, encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle modifications are integral to diabetes control. The most prevalent adverse effect is hypoglycemia (low blood sugar). Familiarize yourself with its symptoms—sweating, vertigo, headache, tremors—and appropriate countermeasures. Maintain regular mealtimes and carry a readily available fast-acting glucose source, such as candy or juice. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur in some individuals. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of cardiovascular disease to your physician before commencing treatment, as it may influence suitability. Pregnant or lactating individuals should seek medical counsel prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.
Uses of Glimu M 2mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glimu M 2mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Glimu M 2mg/500mg Tablet SR. Ingest the tablet whole; do not crush, chew, or break it. Administer this medication with a meal.
Common Side effects of Glimu M 2mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Glimu M 2mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimu M 2mg/500mg Tablet SR whole; do not break, crush, or chew it. Administer this medication with a meal.
How Glimu M 2mg/500mg Tablet SR works:
Glimu M 2mg/500mg Extended-Release Tablets contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, enhances insulin secretion from the pancreas, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Glimu M 2mg/500mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glimu M 2mg/500mg Extended-Release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers before recommending its use. Seek medical advice.
Breast feedingUNSAFE
Prolonged-release Glimu M 2mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Exercise caution when administering Glimu M 2mg/500mg SR tablets to individuals with impaired kidney function; dosage modification may be necessary. Consult a physician for guidance. Glimu M 2mg/500mg SR tablets are contraindicated in patients exhibiting severe kidney disease. Regular monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimu M 2mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Consult a physician for guidance. Low initial doses are typically prescribed for those with mild to moderate liver disease; the medication is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Glimu M 2mg/500mg Tablet SR :
Should you forget to take a Glimu M 2mg/500mg SR tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimu M 2mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Medication |
